Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VASPIT 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/VASPIT 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

VASPIT 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Medochemie Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 15, 2023
Approval ID: fbf7dc12ba7a0b20
Company: Medochemie Limited
Type: Standard

Approval Details

Approval Id: fbf7dc12ba7a0b20
Drug Cima Aemps Name: VASPIT 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 89064
Holder Company Name: Medochemie Limited
Marketing Company Name: Medochemie Iberia S.A. Sucursal En Espana
Authorization Date: 2023-11-15
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 1 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Medochemie Limited

Active Ingredients

PITAVASTATINA CALCIO

1,045 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 15, 2023

Approval ID

fbf7dc12ba7a0b20

Type

Standard

Back to CIMA-AEMPS Approvals